RCE have talked about anti-viral properties in the past, but seem to have been concentrating more on the anti-bacterial side in recent times.
https://www.*.com.au/recce-shares-are-going-nuts-after-announcing-an-anti-viral-drug-2016-7
http://lifesciences.instinctif.com/...ti-viral-activity-for-lead-compound-recce-327
Ann: RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program, page-91
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13550 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18938 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |